Research ArticleOriginal Article
Open Access

Regulation of Lipocalin-2 oncogene and its impact on gene polymorphisms on breast cancer patients in Jeddah, Saudi Arabia

Sabah Linjawi, Zuhoor AlGaithy, Samar Sindi, Norah Hamdi, Ayman Linjawi and Mona Alharbi
Saudi Medical Journal June 2018, 39 (6) 558-563; DOI: https://doi.org/10.15537/smj.2018.6.22950

References

  1. ↵
    1. Alanazi M,
    2. Alabdulkarim HA,
    3. Shaik JP,
    4. Al Naeem A,
    5. Elrobh M,
    6. Al Amri A,
    7. et al.
    (2015) No associations between aromatase gene polymorphisms and breast cancer risk in Saudi patients. Onco Targets Ther 8:2453–2459.
    OpenUrl
  2. ↵
    1. Center MM,
    2. Jemal A,
    3. Smith RA,
    4. Ward E
    (2009) Worldwide variations in colorectal cancer. CA Cancer J Clin 59:366–378.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Almutairi KM,
    2. Mansour EA,
    3. Vinluan JM
    (2016) A cross-sectional assessment of quality of life of breast cancer patients in Saudi Arabia. Public Health 136:117–125.
    OpenUrlPubMed
  4. ↵
    1. Miller KD,
    2. Siegel RL,
    3. Lin CC,
    4. Mariotto AB,
    5. Kramer JL,
    6. Rowland JH,
    7. et al.
    (2016) Cancer treatment and survivorship statistics 2016. CA Cancer J Clin 66:271–289.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Metcalfe K,
    2. Gershman S,
    3. Ghadirian P,
    4. Lynch HT,
    5. Snyder C,
    6. Tung N,
    7. et al.
    (2014) Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. BMJ 348:g226.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Menes TS,
    2. Terry MB,
    3. Goldgar D,
    4. Andrulis IL,
    5. Knight JA,
    6. John EM,
    7. et al.
    (2015) Second primary breast cancer in BRCA1 and BRCA2 mutation carriers:10-year cumulative incidence in the Breast Cancer Family Registry. Breast Cancer Res Treat 151:653–660.
    OpenUrl
  7. ↵
    1. Rodvold JJ,
    2. Mahadevan NR,
    3. Zanetti M
    (2012) Lipocalin 2 in cancer: when good immunity goes bad. Cancer Lett 316:132–138.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Moschen AR,
    2. Adolph TE,
    3. Gerner RR,
    4. Wieser V,
    5. Tilg H
    (2017) Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation. Trends Endocrinol Metab 28:388–397.
    OpenUrl
  9. ↵
    1. Trentmann S,
    2. Matschiner G,
    3. Skerra A,
    4. Hohlbaum A,
    5. Huelsmeyer M,
    6. Gille H,
    7. et al.
    (2017) Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding such (Pieris Pharmaceuticals Gmbh, Germany).
  10. ↵
    1. Soliman NA,
    2. Zineldeen DH,
    3. El-Khadrawy OH
    (2014) Effect of NUCKS-1 overexpression on cytokine profiling in obese women with breast cancer. Asian Pac J Cancer Prev 15:837–845.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Asimakopoulou A,
    2. Borkham-Kamphorst E,
    3. Tacke F,
    4. Weiskirchen R
    (2016) Lipocalin-2 (NGAL/LCN2), a “help-me” signal in organ inflammation. Hepatology 63:669–671.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Jensen-Jarolim E,
    2. Pacios LF,
    3. Bianchini R,
    4. Hofstetter G,
    5. Roth-Walter F
    (2016) Structural similarities of human and mammalian lipocalins, and their function in innate immunity and allergy. Allergy 71:286–294.
    OpenUrl
  13. ↵
    1. Candido S,
    2. Maestro R,
    3. Polesel J,
    4. Catania A,
    5. Maira F,
    6. Signorelli SS,
    7. et al.
    (2014) Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer. Oncotarget 5:1576–1594.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Jung M,
    2. Ören B,
    3. Mora J,
    4. Mertens C,
    5. Dziumbla S,
    6. Popp R,
    7. et al.
    (2016) Lipocalin 2 from macrophages stimulated by tumor cell–derived sphingosine 1-phosphate promotes lymphangiogenesis and tumor metastasis. Sci Signal 9:ra64.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Tung MC,
    2. Hsieh SC,
    3. Yang SF,
    4. Cheng CW,
    5. Tsai RT,
    6. Wang SC,
    7. et al.
    (2013) Knock-down of lipocalin-2 suppresses the growth and invasion of prostate cancer cells. Prostate 73:1281–1290.
    OpenUrl
    1. Wu CH,
    2. Ko JL,
    3. Chen SC,
    4. Lin YW,
    5. Han CP,
    6. Yang TY,
    7. et al.
    (2014) Clinical implications of aldo-keto reductase family 1 member C3 and its relationship with lipocalin 2 in cancer of the uterine cervix. Gynecol Oncol 132:474–82.
    OpenUrl
    1. Yang J,
    2. McNeish B,
    3. Butterfield C,
    4. Moses MA
    (2013) Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer. The FASEB Journal 27:45–50.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    1. Cho H,
    2. Kim JH
    (2009) Lipocalin 2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer. Journal of Histochemistry & Cytochemistry 57:513–521.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Ibrahim EM,
    2. Zeeneldin AA,
    3. Sadiq BB,
    4. Ezzat AA
    (2008) The present and the future of breast cancer burden in the Kingdom of Saudi Arabia. Med Oncol 25:387–393.
    OpenUrlPubMed
  20. ↵
    1. Al-Zaben F,
    2. Sehlo M,
    3. El-deek B,
    4. Koenig H
    (2015) Depressive symptoms, correlates, and the marital relation-ship in women with breast cancer in Saudi Arabia. Women Health Open J 1:53–62.
    OpenUrl
  21. ↵
    1. Almutlaq BA,
    2. Almuazzi RF,
    3. Almuhayfir AA,
    4. Alfouzan AM,
    5. Alshammari BT,
    6. AlAnzi HS,
    7. Ahmed HG
    (2017) Breast cancer in Saudi Arabia and its possible risk factors. Journal of Cancer Policy 12:83–89.
    OpenUrl
  22. ↵
    1. Chen CC,
    2. Feng W,
    3. Lim PX,
    4. Kass EM,
    5. Jasin M
    (2018) Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer. Annual Review of Cancer Biology 2:313–336.
    OpenUrlCrossRef
  23. ↵
    1. Mahfouz MH,
    2. Assiri AM,
    3. Mukhtar MH
    (2016) Assessment of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Retinol-Binding Protein 4 (RBP4) in type 2 diabetic patients with nephropathy. Biomark Insights 11:31–40.
    OpenUrl
  24. ↵
    1. Qurashi S,
    2. Ghamdi G,
    3. Jaradat M,
    4. Tamim H,
    5. Aljumah A,
    6. Tamimi W,
    7. et al.
    (2014) Urinary neutrophil gelatinase-associated lipocalin and the occurrence of delayed graft function after kidney transplant. Exp Clin Transplant 12:396–400.
    OpenUrl
  25. ↵
    1. Fonseca PA,
    2. Rosse IC,
    3. DeMiranda M,
    4. Machado MA,
    5. Verneque RS,
    6. Peixoto MGCD,
    7. Carvalho MRS
    (2013) A new tetra-primer ARMS-PCR for genotyping bovine kappa-casein polymorphisms. Genet Mol Res 12:6521–9526.
    OpenUrl
  26. ↵
    1. Kumar MA,
    2. Singh V,
    3. Naushad SM,
    4. Shanker U,
    5. Narasu ML
    (2018) Microarray-based SNP genotyping to identify genetic risk factors of triple-negative breast cancer (TNBC) in South Indian population. Mol Cell Biochem 442:1–10.
    OpenUrl
  27. ↵
    1. Ören B,
    2. Urosevic J,
    3. Mertens C,
    4. Mora J,
    5. Guiu M,
    6. Gomis RR,
    7. et al.
    (2016) Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis. J Pathol 239:274–285.
    OpenUrlCrossRef
  28. ↵
    1. Wang Y,
    2. Zeng T
    (2013) Neutrophil gelatinase associated lipocalin protein as a biomarker in the diagnosis of breast cancer: A meta analysis. Biomed Rep 1:479–483.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section